- Home
- BCML vs CMPX Comparison
BCML vs CMPX Comparison
Compare BCML & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCML
- CMPX
- Stock Information
- Founded
- BCML 2004
- CMPX 2014
- Country
- BCML United States
- CMPX United States
- Employees
- BCML N/A
- CMPX N/A
- Industry
- BCML Major Banks
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- BCML Finance
- CMPX Health Care
- Exchange
- BCML Nasdaq
- CMPX Nasdaq
- Market Cap
- BCML 261.8M
- CMPX 236.7M
- IPO Year
- BCML N/A
- CMPX N/A
- Fundamental
- Price
- BCML $27.58
- CMPX $1.38
- Analyst Decision
- BCML
- CMPX Strong Buy
- Analyst Count
- BCML 0
- CMPX 3
- Target Price
- BCML N/A
- CMPX $7.67
- AVG Volume (30 Days)
- BCML 26.6K
- CMPX 503.1K
- Earning Date
- BCML 10-17-2024
- CMPX 11-12-2024
- Dividend Yield
- BCML 1.47%
- CMPX N/A
- EPS Growth
- BCML N/A
- CMPX N/A
- EPS
- BCML 2.10
- CMPX N/A
- Revenue
- BCML $96,064,000.00
- CMPX $850,000.00
- Revenue This Year
- BCML N/A
- CMPX N/A
- Revenue Next Year
- BCML $4.79
- CMPX $747.71
- P/E Ratio
- BCML $12.93
- CMPX N/A
- Revenue Growth
- BCML N/A
- CMPX N/A
- 52 Week Low
- BCML $18.54
- CMPX $0.77
- 52 Week High
- BCML $28.62
- CMPX $2.34
- Technical
- Relative Strength Index (RSI)
- BCML 69.23
- CMPX 34.67
- Support Level
- BCML $26.97
- CMPX $1.27
- Resistance Level
- BCML $27.58
- CMPX $1.46
- Average True Range (ATR)
- BCML 0.88
- CMPX 0.14
- MACD
- BCML 0.03
- CMPX -0.05
- Stochastic Oscillator
- BCML 77.49
- CMPX 15.07
About BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.